4 ms·
What a slimy piece of crap: "People hate because they think I'm charging people $750 per pill even though it costs patients less than $10 out of their pocket"
by FireBeyond 11y ago
What a slimy piece of crap:
"People hate because they think I'm charging people $750 per pill even though it costs patients less than $10 out of their pocket"
No.
People hate because you ARE charging $750 per pill. They may only have to pay $10 out of pocket immediately, but one way or another, through co-pays, deductibles, premiums, opportunity cost when employers pay premiums, patients ARE paying $750 per pill.
I highly doubt Shkreli is stupid enough to think that there's a magic pill-paying fairy conjuring $740/pill out of thin air for his benefit, and patients aren't inconvenienced.
But... he DOES think WE are stupid enough to fall for this.
- cma 11y agoMaybe we need a charity that builds a research war chest to threaten companies like this with redevelopment. It costs a lot to replicate a pill and go through the FDA hoops, and once a private company does, the price just gets competed down to the point where it doesn't cover the redevelopment costs. Instead, a charity doesn't have to take profit into consideration and can just threaten: drop your price or we'll persue independent redevelopment. With only the credible threat of spending on independent redevelopment, they could devalue a lot of these orphan drugs, and then buy up the rights/trade secrets to them for open release. Competing businesses can't do this, because they can't pose a credible threat, because following through wouldn't make business sense. A charity can have non-business aims.
- redblacktree 11y agoI like this idea. Where do I donate?
- n0us 11y agoWhat he thinks is that people are going to be outraged over this and new regulations will drive down the stock price of other pharmaceuticals which he has shorted, and if that fails he will still make some money off the pills. It's an excellent bet even if it is extremely immoral.
- eitally 11y agoAnd so far it's working. Look at Valeant for a timely example. And they aren't the only ones facing federal inquiries. http://fortune.com/2015/10/22/valeant-debt/ http://fortune.com/2015/10/22/valeant-debt/ http://www.streetinsider.com/FDA/House+Oversight+Committee+Democrats+Request+Subpoena+of+Valeant+Pharma+(VRX)/10924647.html http://www.streetinsider.com/FDA/House+Oversight+Committee+D... https://aishealth.com/archive/ndbn100915-04 https://aishealth.com/archive/ndbn100915-04
- meric 11y agoHe's taking advantage of government imposed barrier to entry costs. Perhaps by going all out in extracting benefits from the government protection it will point out to the public how much they're being taken advantaged of by the pharmaceutical companies in general and prompt them to demand changes from the authorities. And by tearing down these walls it would benefit his company, because his company is very small startup in the pharmaceutical world. As a startup he doesn't have much incentive to keep the status quo as it is and it is advantageous for him to rock the boat as much as possible. Would he have gotten so much coverage of the inefficient part of the pharmaceutical industry by preaching to the converted, or as he's done and go all out and squeezing it for all he can?